ACUTE DERMAL TOXICITY ASSESSMENT OF "NANOZINC" GEL (TASHPHARMI, UZBEKISTAN)
Vol. 6 No. 4 Part 2 (2026): Eurasian Journal of Academic Research 23-28
Abstract
This study investigated the acute dermal toxicity of "Nanozinc" gel (TashPharmi, Uzbekistan) following topical administration in laboratory animals. The aim of the study was to evaluate the safety and tolerability of a zinc oxide nanoparticle-based gel intended for future use in dermatological formulations. The experiment was performed on sexually mature white mice of both sexes following a single topical application of the gel at different dose levels. The animals were observed continuously during the first hours after administration and subsequently for 14 consecutive days. Clinical observations included general appearance, behavioral changes, locomotor activity, respiration, cardiac activity, food and water intake, body weight, and other indicators of systemic toxicity. No mortality, signs of acute intoxication, behavioral abnormalities, or pathological alterations were observed in any experimental group throughout the observation period. The obtained findings indicate that "Nanozinc" gel does not produce acute toxic effects after topical administration under the experimental conditions employed.These results confirm the safety of topical application of "Nanozinc" gel (TashPharmi, Uzbekistan) and support its further preclinical evaluation as a promising dermatological formulation.
Keywords:
References
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances. 2009;27(1):76–83. https://doi.org/10.1016/j.biotechadv.2008.09.002
Rai M, Yadav A, Gade A. Zinc oxide nanoparticles: A promising approach for skin wound healing. Materials Science and Engineering C. 2017;78:1021–1034. https://doi.org/10.1016/j.msec.2017.05.023
Mohammed YH, Holmes A, Haridass IN, et al. Support for the safe use of zinc oxide nanoparticle sunscreens: Lack of skin penetration or cellular toxicity after repeated application in volunteers. Journal of Investigative Dermatology. 2019;139(2):367–375. https://doi.org/10.1016/j.jid.2018.08.024
Elsaesser A, Howard CV. Toxicology of nanoparticles. Advanced Drug Delivery Reviews. 2012;64(2):129–137. https://doi.org/10.1016/j.addr.2011.09.001
Bian SW, Mudunkotuwa IA, Rupasinghe T, Grassian VH. Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: Influence of pH, ionic strength, size, and adsorption of humic acid. Langmuir. 2011;27(10):6059–6068. https://doi.org/10.1021/la200570n
Ryu HJ, Seo MY, Jung SK, et al. Zinc oxide nanoparticles: A 90-day repeated-dose dermal toxicity study in rats. International Journal of Nanomedicine. 2014;9(Suppl. 2):137–144. https://doi.org/10.2147/IJN.S57930
Khabriev RU, ed. Guidelines for Experimental (Preclinical) Investigation of New Pharmacological Substances. 2nd ed. Moscow: Meditsina; 2005.
Mironov AN, ed. Guidelines for Conducting Preclinical Studies of Medicinal Products. Part I. Moscow: Grif i K; 2012.
Organisation for Economic Co-operation and Development (OECD). Test No. 425: Acute Oral Toxicity—Up-and-Down Procedure. OECD Publishing; 2008. https://doi.org/10.1787/9789264071049-en
ISO 10993-10: Biological Evaluation of Medical Devices—Tests for Irritation and Skin Sensitization. Geneva: International Organization for Standardization.
Morton DB, Jennings M, Buckwell A, et al. Refining procedures for the administration of substances. Laboratory Animals. 2001;35(1):1–41. https://doi.org/10.1258/00236770119
Readership
Downloads
Published
Issue
Section
How to Cite
